RXQ Compounding LLC recalls methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-
Recalled October 25, 2017 · FDA recall D-0012-2018 · RXQ Compounding
Hazard
Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product. · FDA Class II
Units
945 vials
Sold at
TX, LA, PA, MA, FL, and OH
Description
Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.
Product
methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10
Manufacturer(s)
RXQ Compounding LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →